ICU Medical (ICUI) Tops Q4 EPS by 26c

ICU Medical (NASDAQ: ICUI) reported Q4 EPS of $1.77, $0.26 better than the analyst estimate of $1.51. Revenue for the quarter came in at $320.5 million versus the consensus estimate of $295.33 million.

GUIDANCE:

ICU Medical sees Q1 2021 EPS of $6.50-$7.20, versus the consensus of $7.16.

• expects adjusted EBITDA to be in the range of $245 million to $265 million

For earnings history and earnings-related data on ICU Medical (ICUI) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• AeroVironment restates quarterly financials, citing $89M goodwill error
• Accenture downgraded by TD Cowen on AI concerns